Table 1 Summary of 23 Cases of PVT
From: Thrombolytic treatment of prosthetic valve thrombosis: a study using Urokinase
NO | Age(y) Sex | Valve Type | Time from Surgery(m) | NYHA Class | Symptom | UK Dose (0000 IU) | Efficacy | Compli-cations |
|---|---|---|---|---|---|---|---|---|
1 | 46/M | Mitra/ATS | 27 | III | Dyspnea | 225 | CS | No |
2 | 36/M | Mitra /ATS | 38 | II | Dyspnea | 225 | CS | No |
3 | 55/F | Mitra /ATS | 41 | III | APE | 325 | CS | No |
4 | 49/F | Mitra/CM | 1 | IV | Dyspnea | 225 | CS | No |
5 | 67/M | Mitra/ATS | 8 | III | APE | 225 | CS | No |
6 | 40/M | Mitra/SJ | 97 | III | Dyspnea | 525 | F | No |
7 | 58/M | Mitra /ATS | 52 | III | APE | 525 | PS | No |
8 | 62/F | Mitra /ATS | 74 | IV | APE | 425 | CS | No |
9 | 65/M | Mitra /ATS | 21 | III | APE | 325 | F | Cerebral hemorrhage |
10 | 46/M | Mitra /SJ | 18 | II | Dyspnea | 425 | CS | No |
11 | 54/M | Aortic /ATS | 27 | III | APE | 525 | PS | No |
12 | 53/F | Mitra /CM | 22 | III | APE | 525 | F | No |
13 | 48/M | Mitra /ATS | 37 | IV | APE | 225 | CS | No |
14 | 48/M | Mitra /SJ | 45 | IV | Dyspnea | 525 | CS | Urine haemorrhage |
15 | 41/M | Mitra /ATS | 34 | II | Dyspnea | 325 | CS | No |
16 | 65/F | Aortic /ATS | 60 | IV | Dyspnea | 225 | CS | No |
17 | 51/M | Mitra /CM | 55 | IV | Dyspnea | 225 | CS | No |
18 | 62/F | Mitra /SJ | 43 | III | APE | 525 | CS | Urine haemorrhage |
19 | 46/M | Mitra /ATS | 44 | IV | Dyspnea | 525 | F | No |
20 | 44/M | Mitra /SJ | 57 | III | Dyspnea | 325 | CS | No |
21 | 39/M | Mitra /CM | 16 | IV | Dyspnea | 325 | CS | No |
22 | 58/F | Mitra /ATS | 23 | III | Dyspnea | 525 | PS | No |
23 | 45/M | Mitra /SJ | 3 | III | Dyspnea | 225 | CS | No |